SurgePays, Inc. (SURG) - 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by SurgePays, Inc. on November 17, 2021, covering events occurring on November 11, 2021. The filing details the issuance of unregistered equity securities following the closing of a firm commitment underwritten public offering on November 4, 2021.
Key Financial Metrics
The filing does not provide specific revenue, profit, cash flow, margin, debt, or liquidity figures. The primary financial data disclosed relates to the conversion of debt and preferred stock into equity:
- Debt Conversion: $2,415,560 in principal and accrued interest owed to SMDMM Funding, LLC (controlled by the CEO) was converted into 561,758 shares of Common Stock.
- Preferred Stock Conversion: All outstanding Series C Preferred Stock was converted into 3,607,980 shares of Common Stock.
- Total Issuance: 4,169,738 shares of Common Stock were issued on November 11, 2021.
Material Changes
The material change reported is the increase in outstanding Common Stock shares due to the conversion of Series C Preferred Stock and related-party notes payable. This issuance was executed in reliance on the Section 4(a)(2) exemption of the Securities Act, as the shares were sold to three current employees without a public offering.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on future performance, or specific risk factors beyond the standard disclosure of the exemption used for the unregistered sale of securities. No unusual items or contingencies were disclosed in this report.
Investor Verification Checklist
- Verify the total number of outstanding shares post-issuance to assess dilution impact.
- Confirm the valuation of the $2,415,560 debt conversion relative to the current market price of Common Stock.
- Review the final prospectus of the November 4, 2021 public offering for details on the Series C Preferred Stock terms.
- Check subsequent filings for any lock-up agreements or trading restrictions on the shares issued to the CEO, President, and Chief Strategic Officer.